Cromos Pharma is pleased to announce that it has been enlisted to run a clinical trial of a repurposed drug candidate to treat COVID-19. “We are humbled and honored to provide our expertise and our services for the trial that aims to reduce the symptoms of severe COVID-19 pneumonia and ARDS,” said Dr. Vlad Bogin, Cromos Pharma CEO. “It is a wonderful feeling to be joining the fight to end this devastating pandemic that has disrupted the lives of billions of people”. Cromos Pharma will share the details of the trial at a later date, as soon as all of the regulatory and logistical issues are addressed.
CONTACT
INQUIRY@CROMOSPHARMA.COM
To arrange an introductory meeting and find out how our experience can benefit your next clinical project.
